This topic contains a solution. Click here to go to the answer

Author Question: The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to ... (Read 73 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to evaluate the therapeutic response?
 
  1. WBC
  2. PT and INR
  3. BNP
  4. aPTT

Question 2

The client is receiving heparin (Hep-Lock). The nurse will monitor which laboratory results to evaluate therapeutic response?
 
  1. INR
  2. aPTT
  3. BNP
  4. PT



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

izzat

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

2

Rationale 1: WBC is used to determine infection.
Rationale 2: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 3:BNP is incorrect because this lab result does not pertain to clotting.
Rationale 4:aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Global Rationale: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy. PT is incorrect because it should be monitored with INR for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting. aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Answer to Question 2

2

Rationale 1:INR is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 2: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used.
Rationale 3: BNP or beta natriuretic peptide is used for the severity rate of congestive heart failure.
Rationale 4:PT is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.

Global Rationale: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient, and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used. PT and INRare incorrect because they should be monitored for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting.




arivle123

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


bbburns21

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

For a complete list of videos, visit our video library